On March 6, 2025, the research team from the **Shenzhen Pharmaceutical and Medical Device Industry Office** visited our company to conduct a specialized survey on topics such as innovative drug R&D, industry collaboration, and policy support. Our Chairman, **Dr. Zhang Zhefeng**, Vice General Manager **Hou Junqi**, Vice General Manager **Hou Wen**, and relevant business leaders attended the meeting. Both parties engaged in in-depth discussions on the cooperation model for innovative drug projects, investment and financing connections, and Shenzhen's industry policy support. They reached a preliminary consensus on promoting the establishment and development of our company in Shenzhen.

This research visit has laid a solid foundation for future cooperation between both parties. Moving forward, our company will maintain close communication with the **Shenzhen Pharmaceutical and Medical Device Industry Office**, refine the cooperation plan, and promote the substantial implementation of the projects. Together, we aim to inject new momentum into the high-quality development of the pharmaceutical industry.